Menicon Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Menicon Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Menicon Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Menicon Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Menicon Co Ltd (Menicon) manufactures, sells, markets, imports and exports ophthalmic products. The company’s product portfolio includes hard contact lenses, astigmatic contact lens, soft contact lens, and bifocal contact lenses, among others. Menicon also provides periodic replacement type lenses, disposable contact lenses, and lens care products. The company undertakes research and development programs for intraocular lenses. Menicon offers products to optical shops, hospitals, ophthalmic clinics and pharmaceutical wholesalers. The company exports food related materials and import dry foods. It carries out material development, lens designing, and manufacturing of contact lenses and care solutions. The company and its subsidiaries operate through overseas distributors in North America, Latin America, Europe, Africa and the Middle East, Australia, and Asia. Menicon is headquartered in Nagoya, Japan.
Headquarters
Japan
Address
3-21-19, Aoi, Naka-Ku, Nagoya-Shi, Aichi, 460-0006
Website
www.menicon.co.jp
Telephone
81 52 9351515
No of Employees
4,325
Industry
Medical Equipment
Ticker Symbol & Exchange
7780 (TYO)
Revenue (2025)
$796.9M
4.6%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
23.8%
(2025 vs 2024)
Market Cap*
$786.5M
Net Profit Margin (2025)
XYZ
18.4%
(2025 vs 2024)
* As of and is in US$
Menicon Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Vision Care | Menicon Eye Life Support (MELS) Plan | Soft Lenses: |
| Soft Lenses | Veterinary Medical Services | FRUTTIE |
| Gas Permeable (GP) Lenses | Miru | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In July, the company renamed its Chinese contact-lens manufacturing subsidiary Wenzhou FocuSee Vision Care Technologies Co Ltd to Menicon (Wenzhou) Co., Ltd. |
| 2025 | Contracts/Agreements | In June, the company signed a memorandum of understanding with Dr. Agarwals Eye Hospital for the research and development of the myopia control management project. |
| 2025 | Contracts/Agreements | In April, the company and Chubu Electric Power Miraiz signed an agreement for an off-site PPA service utilizing a solar power plant. |
Competitor Comparison
| Key Parameters | Menicon Co Ltd | Seed Co., Ltd | Nirisha Optics Private Limited | Hoya Vision Care | Johnson & Johnson Vision Care Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | India | Singapore | United States of America |
| City | Nagoya-Shi | Bunkyo-Ku | Navrangpura | Singapore City | Jacksonville |
| State/Province | Aichi | Tokyo | Gujarat | - | Florida |
| No. of Employees | 4,325 | 985 | 75 | - | 8,400 |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Koji Kawaura | Chief Executive Officer; Director; President | Executive Board | 2025 | 57 |
| Hideki Koga | Senior Executive Officer; Chief Financial Officer | Senior Management | 2025 | - |
| Kenji Takeshita | Senior Executive Officer; Director - Japan Sales Management Head Office | Senior Management | 2025 | - |
| Nicolaas Johannes Adrianus Engelhart | Senior Executive Officer; Director - International Business Head Office | Senior Management | 2025 | - |
| Motonari Watanabe | Senior Executive Officer; Director - Manufacturing and R&D Head Office | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer